Molecular Infectious Disease Testing Market. Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "Molecular Infectious Disease ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

PCR-Machines are based on Polymerase Chain Reaction (PCR) and produce copies of genes exponentially. The PCR cycling reactions are carried out in an automated thermocycler, which is capable of ...

Zika Virus Testing Market 2032 The global zika virus testing market is set to grow from USD 5.1 Mn in 2025 to USD 6.9 Mn by 2032, registeri ...

Natera (NTRA) announced that the U.S. Patent and Trademark Office has issued Natera a new patent related to testing of single nucleotide ...

Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

Next-generation proteomics is enabling researchers to explore the proteome with unprecedented depth and scale. This article ...

The Co-Dx PCR COVID-19 test is expected to be followed by additional tests for tuberculosis, upper-respiratory multiplex, and a multiplex HPV test, among others. Price Action: CODX stock is down ...

Innovative superRCA technology from Rarity Bioscience AB enhances flow cytometry, expanding oncology research possibilities ...

Market was valued at USD 336.07 million in 2024 and is expected to reach USD 441.23 million by 2033, growing at a CAGR of 4.60% during the forecast period. The market is experiencing substantial ...

How it Works: Real Time PCR Brendan Maher The instrumentation is basic ... Increasingly sophisticated instruments, such as those capable of multiplex experiments, are becoming affordable in academic ...